Detection and half-life of bromobenzene-3,4-oxide in blood
- 1 January 1984
- journal article
- research article
- Published by Taylor & Francis in Xenobiotica
- Vol. 14 (7), 539-543
- https://doi.org/10.3109/00498258409151444
Abstract
Bromobenzene-3,4-oxide can be detected in venous blood of rats by trapping it as the corresponding 35[S]glutathione conjugates. More bromobenzene-3,4-oxide is detected in venous blood of rats treated with phenobarbital and diethyl maleate than in venous blood of rats treated with phenobarbital alone. The half-life of bromobenzene-3,4-oxide in venous blood was about 13.5 s. Bromobenzene-3,4-oxide may contribute to the extrahepatic covalent binding and presumably the toxicity observed after bromobenzene administration. The present technique may be used to determine in blood, the presence or absence of other reactive metabolites that form glutathione conjugates.Keywords
This publication has 8 references indexed in Scilit:
- Activation and detoxification of bromobenzene in extrahepatic tissuesLife Sciences, 1984
- Stereoselective formation of bromobenzene glutathione conjugatesChemico-Biological Interactions, 1982
- Bromobenzene and p-bromophenol toxicity and covalent bindingLife Sciences, 1982
- Bromobenzene-Induced Liver Necrosis. Protective Role of Glutathione and Evidence for 3,4-Bromobenzene Oxide as the Hepatotoxic MetabolitePharmacology, 1974
- Centrolobular hepatic necrosis related to covalent binding of metabolites of halogenated aromatic hydrocarbonsExperimental and Molecular Pathology, 1973
- 3-methylcholanthrene blocks hepatic necrosis induced by administration of bromobenzene or carbon tetrachlorideExperimental and Molecular Pathology, 1971
- Possible Mechanism of Liver Necrosis Caused by Aromatic Organic CompoundsProceedings of the National Academy of Sciences, 1971
- Bromobenzene Metabolism and Hepatic NecrosisPharmacology, 1971